Search research articles
Contact Us
Filters
Showing results (671-680 of 928) with videos related to
Page
of 93
Sort By:
European Heart Journal
|
August 31, 2010
A single dose of erythropoietin in ST-elevation myocardial infarction
Adriaan A Voors, Anne M S Belonje, Felix Zijlstra, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 27, 2014
Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity
Mariëtte R Boon, Sander Kooijman, Andrea D van Dam, et al.
Circulation
|
July 24, 2012
Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts
Baris Gencer, Tinh-Hai Collet, Vanessa Virgini, et al.
BMJ Open
|
March 24, 2018
Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study
David O Riordan, Carole Elodie Aubert, Kieran A Walsh, et al.
American Journal of Epidemiology
|
January 11, 2022
Evaluation of the Value of Waist Circumference and Metabolomics in the Estimation of Visceral Adipose Tissue
Sebastiaan C Boone, Maarten van Smeden, Frits R Rosendaal, et al.
European Heart Journal
|
May 24, 2019
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Harvey D White, Ph Gabriel Steg, Michael Szarek, et al.
Circulation
|
November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Chris J Packard, Ian Ford, Michele Robertson, et al.
Frontiers in Immunology
|
May 29, 2024
CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization
Anjana Singh, Adriaan O Kraaijeveld, Adelina Curaj, et al.
Circulation
|
September 3, 2019
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
Matthew T Roe, Qian H Li, Deepak L Bhatt, et al.
Circulation
|
December 28, 2018
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk
Michelle L O'Donoghue, Sergio Fazio, Robert P Giugliano, et al.
Page
of 93
Search research articles
Search
Showing results (671-680 of 928) with videos related to
Sort By:
Page
of 93
European Heart Journal
|
August 31, 2010
A single dose of erythropoietin in ST-elevation myocardial infarction
Adriaan A Voors, Anne M S Belonje, Felix Zijlstra, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 27, 2014
Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity
Mariëtte R Boon, Sander Kooijman, Andrea D van Dam, et al.
Circulation
|
July 24, 2012
Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts
Baris Gencer, Tinh-Hai Collet, Vanessa Virgini, et al.
BMJ Open
|
March 24, 2018
Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study
David O Riordan, Carole Elodie Aubert, Kieran A Walsh, et al.
American Journal of Epidemiology
|
January 11, 2022
Evaluation of the Value of Waist Circumference and Metabolomics in the Estimation of Visceral Adipose Tissue
Sebastiaan C Boone, Maarten van Smeden, Frits R Rosendaal, et al.
European Heart Journal
|
May 24, 2019
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Harvey D White, Ph Gabriel Steg, Michael Szarek, et al.
Circulation
|
November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Chris J Packard, Ian Ford, Michele Robertson, et al.
Frontiers in Immunology
|
May 29, 2024
CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization
Anjana Singh, Adriaan O Kraaijeveld, Adelina Curaj, et al.
Circulation
|
September 3, 2019
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
Matthew T Roe, Qian H Li, Deepak L Bhatt, et al.
Circulation
|
December 28, 2018
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk
Michelle L O'Donoghue, Sergio Fazio, Robert P Giugliano, et al.
Page
of 93